The CCR5 and CXCR3 chemokine receptors are expressed on Th1 effector cells and are thought to be involved in the development of inflammatory brain lesions in MS while CCR7 is expressed on naive and central memory T cells. The gene discussed is CCR7; the disease is myeloid sarcoma.